Chuck Akre acquired 3.72M SOPHiA Genetics SA shares worth $21.7M. That's 0.33% of their equity portfolio (16th largest holding). The investor owns 5.58% of the outstanding SOPHiA Genetics SA stock. Chuck Akre acquired their 3.72M shares between 2024 and 2025. So far they never sold any shares in the company. The stake costed the investor $15.1M, netting the investor a gain of 44% so far.